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ABSTRACT Aquaporin (AQP) water channels are abun-
dant in the brain and spinal cord, where AQP1 and AQP4 are
believed to play major roles in water metabolism and osmo-
regulation. Immunocytochemical analysis of the brain re-
cently revealed that AQP4 has a highly polarized distribution,
with marked expression in astrocyte end-feet that surround
capillaries and form the glia limitans; however, the structural
organization of AQP4 has remained unknown. In freeze-
fracture replicas, astrocyte end-feet contain abundant square
arrays of intramembrane particles that parallel the distribu-
tion of AQP4. To determine whether astrocyte and ependy-
mocyte square arrays contain AQP4, we employed immuno-
gold labeling of SDS-washed freeze-fracture replicas and
stereoscopic confirmation of tissue binding. Antibodies to
AQP4 directly labeled '33% of square arrays in astrocyte and
ependymocyte plasma membranes in rat brain and spinal
cord. Overall, 84% of labels were present beneath square
arrays; 11% were beneath particle clusters that resembled
square arrays that had been altered during fixation or cleav-
ing; and 5% were beneath the much larger areas of glial
plasma membrane that were devoid of square arrays. Based on
this evidence that AQP4 is concentrated in glial square arrays,
freeze-fracture methods may now provide biophysical insights
regarding neuropathological states in which abnormal f luid
shifts are accompanied by alterations in the aggregation state
or the molecular architecture of square arrays.
Water transport is important in multiple physiological pro-
cesses of the brain and spinal cord, including secretion and
absorption of cerebrospinal f luid, movement of fluid across
the blood–brain barrier, osmosensation, and regulation of
renal water conservation. Precise control of cell volume is
critical, because the brain is encased within the rigid cranium,
and thus, even minor changes in water metabolism may result
in fatal compressive cerebral edema. In other settings, brain
swelling may produce neonatal hydrocephalus, failure of syn-
aptic transmission, or altered neuronal excitability (1–3). Ab-
normal osmoregulation also may contribute to the pathogen-
esis of epilepsy, stroke, and trauma to the brain and spinal cord
(4, 5).
Molecular pathways for the movement of water across
biological membranes were unknown until the discovery of the
aquaporin (AQP) family of membrane water channels (4, 6).
Of these, two AQPs are expressed abundantly in the mamma-
lian brain: AQP1 in the choroid plexus of the ventricles (where
it apparently mediates secretion of cerebrospinal f luid; see
refs. 4 and 7) and AQP4 in plasma membranes of ependymal
cells and astrocytes, particularly in astrocyte end-feet that form
the glia limitans and that surround capillaries (3). AQP4 is
especially abundant in astrocytes and ependymocytes in os-
mosensory areas, including the supraoptic nucleus and sub-
fornical organ (3). These sites suggest a role for AQP4 in water
transport between the brain parenchyma, cerebrospinal f luid,
and blood, as well as a role in osmoregulation.
Naturally occurring membranes enriched in AQP1 contain
intramembrane particles (IMPs). Nevertheless, membrane re-
constitution of AQP1 at high concentration yielded highly
ordered two-dimensional crystalline lattices of AQP1, with a
tetrameric assembly of subunits (8). The major intrinsic pro-
tein of lens MIP26 (or AQP0) occurs in lens fibers as tetragonal
arrays (9). Similar “square arrays”** also are found in the renal
collecting-duct principal cell, where multiple AQPs are ex-
pressed (12). These precedents suggest that some AQPs reside
in native tissues as square arrays.
In contrast, early freeze-fracture studies of astrocyte end-
feet revealed an abundance of naturally occurring square
arrays of IMPs in the plasma membranes directly facing
capillaries, as well as in the end-feet that form the glia limitans
bordering the subarachnoid space (13–15). These areas cor-
respond to the sites were AQP4 is expressed (3). The possibility
that square arrays in the brain and spinal cord are formed from
AQP4 was also suggested by the apparent absence of square
arrays in brains from mice with AQP4 gene disruption (16). By
using a new direct-labeling method for fracture-labeling IMPs
in SDS-washed membranes (17), we sought to establish
whether AQP4 proteins (i) are organized within square arrays
in astrocytes and ependymocytes from rat brain and spinal
cord, (ii) exist primarily as dispersed IMPs outside of square
arrays, or (iii) occur in both clustered and dispersed IMP
distributions.
MATERIALS AND METHODS
Antibodies and Immunogold Labels. For correlation with
data from previous reports (3), affinity-purified antibodies to
rat AQP4 were generated against a synthetic peptide corre-
sponding to amino acids 280–296 (LL182; see ref. 18), a
domain predicted to lie in the middle of the 71-residue
cytoplasmic C terminus (19). Monoclonal antibodies to gap-
junction connexin-43 (Cx43) and polyclonal antibodies conju-
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**These distinctive IMP arrays were originally called ‘‘rectilinear
arrays’’ (10), but subsequently have been called ‘‘square arrays,’’
‘‘rectangular arrays,’’ ‘‘orthogonal arrays,’’ ‘‘orthogonal assemblies,’’
‘‘assemblies,’’ ‘‘orthogonally arranged particles’’ (or ‘‘OAPs’’), and
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these arrays are composed of equilateral rectangles, we employ the
term ‘‘square arrays,’’ which more accurately describes the organi-
zation of their subunits.
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gated to 10- and 20-nm gold beads (goat anti-mouse and goat
anti-rabbit IgG) were obtained from Chemicon.
Animals. For light-microscopic and thin-section electron-
microscopic immunocytochemistry, rats were perfused with
0.1% glutaraldehyde and 2% formaldehyde in 0.1 M cacody-
late, pH 7.4. For freeze-fracture immunocytochemistry, adult
Sprague–Dawley rats (two males and eight females) were fixed
for 10 min by perfusion with 1% formaldehyde in Sorenson’s
phosphate buffer (SPB), pH 7.4.
Immunoblotting. Cerebellum, spinal cord, and cerebral
cortex (including hippocampus) were homogenized (0.3 M
sucrosey25 mM imidazoley1 mM EDTA, pH 7.2y8.5 mM
leupeptiny1 mM phenylmethylsulfonyl f luoride). After cen-
trifugation at 4,000 3 g for 15 min at 4°C, the supernatant was
centrifuged at 17,000 or 200,000 3 g for 1 h. Pellets were
solubilized in Laemmli sample buffer containing 2% SDS and
run on 12% polyacrylamide minigels. Immunoblots were an-
alyzed with affinity-purified anti-AQP4 (18) and visualized
with the Enhanced Chemiluminescence System (Amersham).
Immunocytochemistry. Fixed-tissue blocks of brain and
spinal cord were infiltrated for 30 min with 2.3 M sucrose
containing 2% formaldehyde, mounted on holders, and rapidly
frozen in liquid nitrogen. For light-microscopic immunocyto-
chemistry, frozen-tissue blocks were cryosectioned (0.8 mm;
Ultracut S Cryoultramicrotome, Reichert), and sections were
incubated with affinity-purified anti-AQP4 antibodies. Label-
ing with horseradish peroxidase-conjugated secondary anti-
body (P448 1:100; Dako) was visualized (i.e., amplified) with
diaminobenzidine. For immunoelectron microscopy, frozen
blocks were freeze-substituted and embedded in Lowicryl
HM20 (Reichert). Ultrathin sections (40–60 nm) were incu-
bated with affinity-purified anti-AQP4. Labeling was visual-
ized with goat anti-rabbit IgG conjugated to 10-nm colloidal
gold particles (Biocell Laboratories).
Freeze-Fracture Immunocytochemistry. Vibratome brain
slices were cut from the suprachiasmatic nucleus and hip-
pocampus; spinal-cord slices were cut from the mid-thoracic
level. Tissue slices were frozen ultrarapidly with a metal-mirror
freezing device (20), freeze-fractured at 2175 to 2185°C in a
JEOL RFD-9010C freeze-fracture device, shadowed with #1
nm of platinumycarbon, and replicated with 10 nm of pure
carbon (21). Frozen replicated samples were bonded to a gold
index grid by using 2% Lexan plastic (GE Plastics, Pittsfield,
MA) that had been dissolved in dichloroethane, thawed, and
photography-mapped by confocal microscopy (22). Tissue
components other than membrane proteins adsorbed to the
platinumycarbon replica were removed by washing the replicas
in 2.5% SDS in 10 mM TriszHCl, pH 8.6 for 18–24 h at 37–55°C
with constant stirring (modified from the procedure described
in ref. 17). Samples were rinsed three times in SPB and
immersed for 30 min in ‘‘labeling-blocking buffer’’ (LBB),
which consisted of 10% heat-inactivated goat serum and 0.5%
teleost gelatin (Sigma) in 0.15 M SPB (23). LBB-protected
replicas were placed in primary antibody solution (1:100 in
LBB). For double-labeling experiments, species-specific pri-
mary antibodies were mixed in LBB, as were the species-
specific immunogold secondary antibodies. After secondary
labeling for 90 min, samples were rinsed five times (25 min
total) in SPB, three times in distilled water, and air dried. In
double-labeling experiments, each label served as a control for
the other label, thereby allowing sources and rates of nonspe-
cific and ‘‘false-negative’’ labeling to be identified.
After labeling, replicas were coated on the (former) tissue
side with a second 10-nm carbon layer, which prevented the
displacement of gold labels during the subsequent removal of
the Lexan support film (22). Replicas were examined in a
JEOL 2000 EX-II transmission electron microscope operated
at 100 kV. Selected images are presented as stereoscopic
images (included angle of 8°) to document that specific gold
labels were present only on the cytoplasmic side of the replica.
Analysis of Immunogold Labeling. After membrane split-
ting and replication with platinumycarbon, vigorous washing
with SDS dissolves away most of the tissue. However, sufficient
numbers of the replicated proteins remain adsorbed to the
replica to permit direct immunocytochemical labeling and
semiquantitative analysis (17, 24). This method is best suited
for studying densely packed protein arrays consisting of iden-
tical epitopes.
We photographed 10 replicas from 10 labeling experiments,
yielding 24 areas of astrocyte and ependymocyte plasma
membrane totaling 24 mm2 (range: 0.1–3.5 mm2 per image).
Gold labels were counted beneath (i) P-face square arrays; (ii)
E-face square arrays; (iii) IMP clusters on astrocyte and
ependymocyte membrane P faces; (iv) P faces that did not
contain square arrays or IMP clusters; (v) surrounding areas of
replicated extracellular space; and (vi) replicated plasma mem-
branes of neurons, oligodendrocytes, and vascular endothelial
cells. Analysis of the latter two areas allowed rates of nonspe-
cific binding to be determined.
Gold beads were defined as associated with square arrays if
they were located directly beneath or within 20 nm of the array
(i.e., within a radius two antibody molecules in length). The
density of gold labels (no. per mm2) was calculated for square
arrays (alone) and for areas of astrocyte and ependymocyte
plasma membranes devoid of square arrays. These values were
compared as an estimate of the ratio of AQP4 in assembled vs.
unassembled states.
RESULTS
Specificity of Anti-AQP4. As reported (3), affinity-purified
anti-AQP4 recognized 29- and 31-kDa bands, corresponding
to the two alternative translation-initiation variants of AQP4
(Fig. 1A), as well as a higher molecular mass band correspond-
ing to undissociated oligomeric AQP4. Immunocytochemical
staining revealed abundant labeling of glial processes in thin
cryosections of spinal cord (Fig. 1B), cerebellum, and hip-
pocampus (3). Prominent labeling appeared in pericapillary
glial processes (indicated by arrows in Fig. 1B) and glia
limitans, but other astrocyte processes were labeled weakly or
not at all.
In ultrathin Lowicryl sections of cerebellum (Fig. 1C) and
spinal cord, immunoelectron microscopy revealed abundant
labeling of AQP4 in glial processes adjacent to capillary
endothelium, with negligible labeling of other glial membrane
domains. Thus, AQP4 immunolabeling has a distinctly polar-
ized distribution, primarily adjacent to capillary end-feet, the
glia limitans, and ependymal-cell basolateral plasma mem-
branes (3). Immunolabeling controls performed with nonim-
mune IgG or peptide-adsorbed anti-AQP4 were negative (not
shown).
AQP4 Labeling in Freeze-Fracture Replicas of Ependymal
Cells. Samples from rat brain and spinal cord were labeled with
anti-AQP4 or with anti-AQP4 plus anti-Cx43. At low magni-
fication, conspicuous 20-nm gold particles revealed the pres-
ence of Cx43 in gap junctions of ependymal cells (Fig. 2A),
confirming previous immunocytochemical studies (25). Dis-
crete (nonclumped) anti-Cx43 gold labels were present at
100–300 per mm2 in gap junctions vs. 0.1–1 per mm2 in
nonjunctional plasma membranes, thereby showing labeling
with high specificity, moderate efficiency, and low background.
In double-labeled ependymocytes, anti-AQP4y10-nm gold
labels were restricted almost exclusively to the relatively rare
square arrays (Fig. 2 A, inscribed area; shown in a higher-
magnification stereoscopic image in Fig. 2B). Stereoscopic
images showed that .99.5% of labels were attached beneath
the replica (Fig. 2C). Gold-labeled square arrays adjacent to
Cx43-labeled gap junctions (Fig. 2C) confirmed the differen-
tial specificity of anti-Cx43 labels for ependymocyte and
astrocyte gap junctions vs. anti-AQP4 labels for square arrays.
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Moreover, minimal nonspecific labeling was observed, and no
interaction of species-specific primary and secondary antibody
labels was detected.
‘‘Cryptic’’ labeling of undissolved remnants of gap junctions
was seen at the margins of oblique- and crossfractured gap
junctions (indicated by black arrows in Fig. 2C). Cryptic
labeling extended up to 0.3 mm beyond the visible-margin
portion of the gap junction and projected beneath the inter-
vening replicated cytoplasm. (The samples were air dried,
causing the labels to collapse against the replica.) In other
labeled replica samples prepared by glutaraldehydeyosmium
fixation and staining with uranyl acetateylead citrate and
examined as ‘‘whole mounts,’’ the labeled membrane debris
was found to contain partially dissolved gap junctions. Thus,
incompletely dissolved membrane fragments account for the
cryptic labeling seen in unstained replicas (J.E.R. and T.Y.,
unpublished work). These data suggest that at the boundary
layer between replica and tissue, unfractured and unreplicated
membrane fragments are not always dissolved completely. The
undissolved fragments may remain attached to and continuous
with the replicated portions of gap junctions and other struc-
tures, thereby providing the basis for “cryptic” labeling in
unstained replicas.
AQP4 Labeling of Astrocyte End-Feet. Square arrays are
most abundant in astrocyte end-feet surrounding capillaries
and in the glia limitans, where they may reach densities of
300–500 per mm2 (11). In samples of the glia limitans that had
been single-labeled with anti-AQP4, 10-nm gold beads were
present beneath astrocyte plasma membrane P faces (Fig. 3).
All other areas of the replica (including extracellular space and
nonastrocyte membranes) were essentially devoid of gold
labels (left side of Fig. 3A), thereby showing a low level of
nonspecific labeling.
In 24 mm2 of astrocyte plus ependymocyte plasma mem-
brane, 183 gold beads were bound to 558 square arrays (i.e.,
'33% of square arrays were labeled). For example, of '50
square arrays in the area included in Fig. 3B, 17 (or 34%) were
labeled; two gold beads were associated with clusters of IMPs
that were not clearly identifiable as square arrays (see ref. 26),
and four gold beads at the edge of the replicated portion of the
astrocyte plasma membrane were attributed to cryptic labeling
(see above). Labels were not found to be associated with the
E face images of square arrays. Thus, AQP4-immunogold
labeling was exclusively associated with P face replicas of
square arrays. Based on an average area of 1270 nm2 per
square array (or 1y800 mm2; see ref. 11 for similar estimates of
maximum square array density), labeling density for square
arrays was calculated to be 272 gold beads per mm2 of IMP
lattice, equivalent to that observed for immunogold labeling of
connexons within gap junctions.
Overall, gold labels on astrocyte and ependymocyte plasma
membrane were present at 9.1 per mm2 of astrocyte and
ependymocyte plasma membranes. Of these, 7.6 per mm2 (or
84%) were directly associated with square arrays, and 1.0 per
mm2 (11%) were associated with square-array-sized clusters of
distinctive elongated IMPs. (These may represent square
arrays that had been altered by circulatory arrest during
fixation; ref. 26.) The remaining 0.5 gold label per mm2 (5.5%)
was observed in areas of plasma membrane that did not
contain square arrays or IMP clusters. Nonspecific labeling of
plasma membranes of other cell types, as well as on replicas of
the extracellular space, was very low (,0.06 per mm2; area
analyzed 5 62.3 mm2). From these data, we calculated a
‘‘signal-to-noise’’ ratio (23) of '4000:1 (based on signal of 272
gold beads per mm2 for square arrays vs. noise of 0.06 per mm2).
At high magnification (Fig. 3 C–F), 2-nm crossbridges were
seen to link the constituent IMPs of square arrays. (Fig. 3 C and
D are printed with conventional ‘‘white shadows.’’ Fig. 3 E and
F are printed with black shadows, which better reveal molec-
ular detail. See ref. 21 for additional details of square-array
substructure.) The identity of the 2-nm crossbridges linking
IMPs within the square arrays is currently unknown, but they
represent intramembrane domains of the square-array pro-
teins, possibly including the B and E loops of AQP4 (4, 27).
The crossbridges may contribute to the formation of the square
lattice of IMPs, to the structural integrity of the arrays, or to
possible stretch sensitivity of AQP4 water channels as estab-
lished for ion channels (28).
DISCUSSION
We have demonstrated direct immunogold labeling of AQP4
in square arrays in SDS-washed grid-mapped fracture rep-
licas of astrocyte and ependymocyte plasma membranes
from brain and spinal cord of mature rats. Labeling paral-
leled the distribution of AQP4 proteins in astrocyte plasma
FIG. 1. (A) Immunoblot of membrane fractions from spinal cord, cerebellum, and cerebral cortex (plus hippocampus). The blot was probed
with affinity-purified anti-AQP4 and shows 29- and 31-kDa bands (splice variants) and a higher molecular mass band (undissociated-AQP4
oligomers). (B) Thin cryosection (0.9 mm) of spinal cord. Extensive AQP4-immunolabeling is observed on glial processes adjacent to capillaries
(arrows) and adjacent to neurons (arrowhead). (3670.) (C) Ultrathin Lowicryl section of cerebellum. AQP4-labeling is associated with the glial
process (G) on the side directly facing the capillary endothelium (E). (372,000.)
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membranes as demonstrated by thin-section immunogold
labeling (3). Within astroglial end-feet, 85–95% of AQP4
labeling was present beneath square arrays. Nevertheless,
because the remaining surface area of astroglial cells is much
larger than the portion present in end-feet, a significant
portion of AQP4 could exist in those areas but at such a low
concentration that it would not be detectable by our meth-
ods.
AQP4 antibodies label approximately the same proportion
of IMPs in square arrays as connexin antibodies label IMPs
in gap junctions (1–3% of IMPs; 100–300 labels per mm2 in
both cases). These proportions support the hypothesis that
AQP4 is the major component of square arrays. Neverthe-
less, our data do not preclude the possibility that accessory
proteins may be present within the arrays, or that several
classes of proteins may reside within an IMP array. For
example, multiple connexins reside within individual gap
junctions (29), and occludin and ZO-1 reside within liver
tight-junction strands (17, 24). Thus, precedent establishes
that multiple protein isoforms, and even multiple proteins,
FIG. 2. Replica of ependymal-cell plasma membrane in section of suprachiasmatic nucleus after double-labeling with anti-Cx43y20-nm gold
beads and anti-AQP4y10 nm-gold beads. (A) The single gap junction seen in this image has 22 large gold beads beneath or within 20 nm of P face
IMPs and E face pits. No other 20-nm gold beads are present. Calibration bars in all freeze-fracture images represent 0.1 mm. (385,000.) (B)
Inscribed area from Fig. 2 A that contains four anti-AQP4y10-nm gold particles beneath five square arrays (black arrows). Three additional square
arrays are unlabeled (white arrows). The high angle of shadowing in this area resulted in reduced specimen contrast. (3130,000.) (C) AQP4y10-nm
gold-labeled square array adjacent to Cx43y20-nm gold-labeled gap junction between ependymal cells in spinal cord. The white arrow points to
AQP4y10-nm gold-labeled square array (shown at higher magnification in the inset image). Black arrows point to cryptic labeling of an unreplicated
portion of the gap junction (see text). (370,000; Inset 3135,000.)
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may be present in structurally homogenous IMP arrays.
Square arrays may be no exception.
Historical Perspectives Regarding Square Arrays. Square
arrays have been observed in freeze-fracture replicas for more
than 30 years (reviewed in ref. 11). Although substantial
circumstantial evidence could have implicated AQP4 as a
component in astrocyte square arrays (3, 12), it was known that
AQPs in addition to AQP4 are present in other membranes
that are enriched in square arrays. For example, AQP0 (or
MIP26) is expressed only in lens-fiber cell membranes, where
its presence in square arrays was documented by fracture-
labeling (9). Moreover, because AQP0 is the major intrinsic
protein of lens (constituting more than 50% of membrane
protein, with much of the remainder consisting of connexins),
lens square arrays necessarily consist predominantly of a single
protein, AQP0. Likewise, the presence of the homolog AQPcic
coincides with the distribution of square arrays in the water-
channel-enriched filter chambers of sap-sucking insects (30).
Moreover, square arrays appeared in cultured cell lines trans-
fected with Aqp4 (31) but were absent in tissues from mice with
disruption of the AQP4 gene (16). In contrast, at least one
AQP, AQP1, does not occur naturally in square arrays in the
FIG. 3. High-specificity anti-AQP4y10-nm gold labeling of square arrays in astrocyte end-feet. (A) Gold labels are confined almost exclusively
to the astrocyte end-feet. No gold beads are seen on other membranes or attached to the replicated extracellular matrix (on the left side of the
image). (370,000.) (B) Stereoscopic image of the area inscribed in A reveals 17 gold particles directly beneath square arrays. (3135,000.) (C–F)
High-magnification stereoscopic images of labeled AQP4 square arrays (C and D printed with white shadows; E and F printed with black shadows).
In images printed with black shadows, 2-nm crossbridges (indicated by an arrow in E) are resolved linking the subunit IMPs (see text and ref. 21).
(3450,000.)
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choroid plexus or in erythrocytes, but AQP1 does form square
lattices in artificial membrane bilayers (8).
Perivascular end-feet of rat-brain astrocytes (32) were
known to be particularly enriched in square arrays (500–600
square arrays per mm2; ref. 11), whereas nonadjacent mem-
brane domains had markedly reduced densities of square
arrays (33). This distribution precisely reflected the areas of
plasma membrane where AQP4 was identified by immunogold
electron microscopy (3). However, strict correlation was not
possible because the astrocyte end-feet also contained high
concentrations of potassium ‘‘leakage’’ channels (34). Never-
theless, in rat brains, the developmental expression of square
arrays (14) was remarkably similar to the ontogeny of AQP4
(19), and the presence of square arrays in paravitreous and
perivascular end-feet of retinal Müller cells (35) was found to
coincide exactly with the sites where AQP4 was shown by
immunogold labeling of retina (36). In other tissues (tracheal
epithelium, ref. 37; fast-twitch skeletal muscle fiber, refs. 38
and 39; and renal collecting duct, ref. 40), the presence of
square arrays has been correlated with immunohistochemically
identified AQP4 (12, 41, 42) or with areas of AQP4 expression
(18). These observations heightened our suspicion that AQP4
is present within square arrays in brain and spinal cord.
However, in none of these cases was direct labeling of square
arrays demonstrated.
Potential Relevance to Central Nervous System Trauma
and Disease. Recognition that square arrays in astrocyte and
ependymocyte plasma membranes are composed of AQP4
provides insight into the functions of these structures. Inter-
estingly, the prediction that square arrays in renal collecting-
duct cells are involved in cellular water transport predated the
discovery of AQPs (40); however, the hypothesis appears to be
correct. Also interesting are suggestions that square arrays may
participate in potassium-channel activation (43) or potassium-
buffering during neuronal activation (32, 34). This may reflect
parallel distributions of unrelated proteins. Alternatively, co-
ordination of the activities of separate AQP4 and potassium-
leak channels may facilitate ‘‘potassium-siphoning’’ at astro-
cyte end-feet (44, 45) during osmoregulatory activity that
follows both synaptic transmission and repetitive nerve firing.
AQP4 square-array-mediated water transport also may be of
significance in several pathological conditions affecting the
central nervous system. Square arrays are reported to be
reduced or disrupted in astrocytes after circulatory arrest (ref.
26; compare ref. 11), and the inability to dissipate cerebral
edema may reflect a reduction in levels of AQP4 or an altered
assembly or distribution of the protein. Observations that
reactive astrocytes exhibit reduced polarity (33) suggest that
altered expression of AQP4 may contribute to recovery from
neural injury. These observations warrant further investiga-
tion; applying fracture-labeling methods to tissues from these
clinical disorders and others, such as epilepsy and hydroceph-
alus, may help to define alterations in the distribution of AQP4
square arrays during disruptions of water metabolism within
the central nervous system.
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